Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2026-01-03 @ 2:02 PM
Study NCT ID:
NCT04643067
Status:
COMPLETED
Last Update Posted:
2024-05-23
First Post:
2020-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE
Sponsor:
Kangpu Biopharmaceuticals, Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | SLE; Drug | View |
Keywords: